These Analysts Boost Their Forecasts On Cinemark Following Upbeat Earnings

Cinemark Holdings Inc CNK reported better-than-expected second-quarter financial results on Friday.

Cinemark reported a fiscal second-quarter 2024 sales decline of 22.1% year-on-year to $734.2 million, beating the analyst consensus estimate of $691.6 million. EPS of 32 cents beat the analyst consensus estimate of 9 cents.

Admissions revenue decreased 23.5% to $365.8 million, and concession revenue declined 21.6% to $292.9 million, driven by a 22.4% decrease in attendance to 50.0 million patrons.

"Numerous films across varied genres delivered solid results, including June's record-breaking release of Inside Out 2 – now the biggest animated title of all time – which drove cumulative Q2 box office performance beyond our expectations despite headwinds caused by last year's strikes in Hollywood," stated Sean Gamble, Cinemark President and CEO.

Cinemark shares gained 0.9% to trade at $25.08 on Monday.

These analysts made changes to their price targets on Cinemark following earnings announcement.

  • JP Morgan analyst David Karnovsky maintained Cinemark with a Neutral and raised the price target from $22 to $25.
  • B. Riley Securities analyst Eric Wold maintained the stock with a Buy and increased the price target from $27 to $31.
  • Barrington Research analyst James Goss maintained Cinemark with an Outperform rating and raised the price target from $24 to $28.
  • Roth MKM analyst Eric Handler maintained the stock with a Buy and boosted the price target from $28 to $30.
  • Morgan Stanley analyst Benjamin Swinburne maintained Cinemark with an Overweight rating, while boosting the price target from $26 to $29.

Read Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPrice TargetMarketsAnalyst RatingsTrading IdeasPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!